Cardiac Troponin I and T Are Associated with Left Ventricular Function and Structure: Data from the Akershus Cardiac
Magnus Nakrem Lyngbakken1,2, Erika Nerdrum Aagaard1,2, Brede Kvisvik1,2
1Department of Cardiology, Division of Medicine, Akershus University Hospital, Lørenskog, Norway.
Insights
Cardiac troponin I (cTnI) and T (cTnT) levels indicate different cardiovascular risks. cTnI better predicts subclinical left ventricular hypertrophy than cTnT in the general population.
Area of Science:
- Cardiology
- Biomarkers
- Cardiovascular Disease
Background:
- Cardiac troponin I (cTnI) and T (cTnT) correlate with cardiac outcomes but not closely in the general population.
- Hypothesized that cTnI and cTnT are influenced by different cardiovascular (CV) and non-CV risk factors, reflecting distinct CV phenotypes.
Purpose of the Study:
- To investigate the differential associations of cTnI and cTnT with CV and non-CV risk factors.
- To determine the relationship between cTnI, cTnT, and subclinical cardiovascular disease, particularly left ventricular hypertrophy and dysfunction.
Main Methods:
- Prospective observational study of 1236 women and 1157 men from the Akershus Cardiac Examination 1950 Study.
- Measured cTnI and cTnT using last-generation assays in individuals without known CV disease.
- Extensive CV phenotyping, including detailed echocardiography, was performed at baseline.
Main Results:
- cTnI was measurable in 60.3% and cTnT in 72.5% of participants; moderate correlation (r=0.53).
- cTnI associated with male sex, higher education, hypertension, and age; cTnT associated with eGFR.
- Both troponins inversely associated with global longitudinal strain and positively with LV mass index (LVMI); cTnI association with LVMI was stronger.
- cTnI improved diagnostic accuracy for LV hypertrophy, while cTnT did not.
Conclusions:
- cTnI and cTnT concentrations are linked to subclinical LV hypertrophy and dysfunction in a community-based cohort.
- cTnI demonstrates superior predictive value for subclinical left ventricular hypertrophy compared to cTnT.
Background:
Concentrations of cardiac troponin I (cTnI) and T (cTnT) are associated with clinical cardiac outcomes, but do not correlate closely in subjects recruited from the general population. Accordingly, we hypothesized that cTnI and cTnT concentrations would be influenced by different cardiovascular (CV) and non-CV risk factors and reflect different CV phenotypes.
Methods:
We measured cTnI and cTnT with last generation assays in 1236 women and 1157 men with no known CV disease participating in the prospective observational Akershus Cardiac Examination 1950 Study. All study participants underwent extensive CV phenotyping at baseline, including detailed echocardiography.
Results:
Concentrations of cTnI were measurable in 60.3% and cTnT in 72.5% of study participants (P < 0.001), and correlated moderately (r = 0.53; P < 0.001). cTnI was more strongly associated with male sex (P = 0.018), higher education (P < 0.001), history of hypertension (P < 0.001), and age (P < 0.001), whereas cTnT was more strongly associated with eGFR (P = 0.015). Both cTnI and cTnT were inversely associated with global longitudinal strain and positively associated with LV mass index (LVMI) in analyses adjusted for CV risk factors. The association between cTnI and LVMI was stronger than the association between cTnT and LVMI (P = 0.035). Concentrations of cTnI improved diagnostic accuracy for LV hypertrophy when added to established CV risk factors, but concentrations of cTnT did not improve these models further.
Conclusions:
In a large community-based cohort examined with extensive echocardiography, concentrations of cTnI and cTnT are associated with subclinical LV hypertrophy and dysfunction. Concentrations of cTnI appear superior to cTnT in predicting subclinical LV hypertrophy.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Imaging Studies for Cardiovascular System V: CT
Dysrhythmias V: Evaluating Dysrhythmias


